Skip to content

Clinical trials

Mental Disorders trials in Russia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Mental Disorders Country / region: Russia Clear all

19 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20081
20091
20102
20113
20122
20132
20142
20161
20181
20201
20212
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed15
Terminated3
Active, not recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Otsuka Pharmaceutical Development & Commercialization, Inc.6
Forest Laboratories2
Pfizer2
AO GENERIUM1
AstraZeneca1
H. Lundbeck A/S1
Hoffmann-La Roche1
Novartis Pharmaceuticals1
Pierre Fabre Medicament1
S.LAB (SOLOWAYS)1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Mental Disorders19
Nervous System Diseases6
Alzheimer Disease5
Dementia5
Major Depressive Disorder5
Mood Disorders5
Cognitive Dysfunction4
Depressive Disorder4
Psychomotor Agitation3
Schizophrenia3

Trials

Showing 26 to 19 of 19. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.